Hematopoietic stem cell transplantation for profound T-cell deficiency (combined immunodeficiency)

Immunology and Allergy Clinics of North America

Volumn 30, Issue 2, 2010, Pages 209-219

  Roifman, Chaim M ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Engraftment; HSCT; Mutation; Profound T cell dysfunction

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYELOABLATIVE AGENT;

COMBINED IMMUNODEFICIENCY; ENGRAFTMENT; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE COUNT; MYELOABLATIVE CONDITIONING; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; T LYMPHOCYTE; TREATMENT INDICATION; GENETICS; IMMUNE SYSTEM; IMMUNOLOGY; INFANT; METABOLISM; PATHOLOGY; POSTOPERATIVE COMPLICATIONS; TRANSPLANTATION TOLERANCE;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNE SYSTEM; INFANT; MYELOABLATIVE AGONISTS; POSTOPERATIVE COMPLICATIONS; SEVERE COMBINED IMMUNODEFICIENCY; T-LYMPHOCYTES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION TOLERANCE;

EID: 77953000914     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2010.03.001     Document Type: Review

References (31)

1. Arpaia E., Shahar M., Dadi H., et al. Defective T cell receptor signaling and CD8+ thymic selection in humans lacking Zap-70 kinase. Cell 1994, 76:947-958.
2. Sharfe N., Dadi H.K., Shahar M., et al. Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor. Proc Natl Acad Sci U S A 1997, 94:3168-3171.
3. Alarcon B., Regueiro J.R., Arnaiz-Villena A., et al. Familial defect in the surface of expression of the T-cell receptor CD3 complex. N Engl J Med 1988, 319:1203-1208.
4. Sharfe N., Shahar M., Roifman C.M. An interleukin-2 receptor γ chain mutation with normal thymus morphology. J Clin Invest 1997, 100:3036-3043.
5. Somech R., Roifman C.M. Mutation analysis should be performed to rule out γc deficiency in children with functional severe combined immune deficiency despite apparently normal immunologic tests. J Pediatr 2005, 147:555-557.
6. Zhang J., Quintal L., Atkinson A., et al. Novel RAG1 mutation in a case of severe combined immunodeficiency. Pediatrics 2005, 116:e445-e449.
7. Roifman C.M., Gu Y., Cohen A. Mutations in the RNA component of Rnase MRP cause Omenn syndrome. J Allergy Clin Immunol 2006, 117:897-903.
8. Notarangelo L.D., Giliani S., Mazza C., et al. Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency: defects of the gamma(c)-JAK3 signaling pathway as a model. Immunol Rev 2000, 178:39-48.
9. Timon M., Arnaiz-Villena A., RodroAguez-Gallego C., et al. Selective disbalances of peripheral blood T lymphocyte subsets in human CD3 gamma deficiency. Eur J Immunol 1993, 23:1440.
10. Bennet C.L., Christie J., Ramsdell F., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001, 27(1):20-21.
11. Roifman C.M., Hummel D.B., Martinez-Valdez H., et al. Depletion of CD8+ cells in human thymic medulla results in selective immune deficiency. J Exp Med 1989, 170(6):2177-2182.
12. Roifman C.M. Human IL-2 receptor alpha chain deficiency. Pediatr Res 2000, 48(1):6-11.
13. Villa A., Santagata S., Bozzi F., et al. Partial V(D)J recombination activity leads to Omenn syndrome. Cell 1998, 93:885-896.
14. Or Ege M., Ma Y., Manfras B., et al. Omenn syndrome due to ARTEMIS mutations. Blood 2005, 105(11):4179-4186.
15. Grunebaum E., Bates A., Roifman C.M. Omenn syndrome is associated with mutations in DNA ligase IV. J Allergy Clin Immunol 2008, 122(6):1219-1220.
16. Shibata F., Toma T., Wada T., et al. Skin infiltration of CD56(bright) CD16(-) natural killer cells in a case of X-SCID with Omenn syndrome like manifestations. Eur J Haematol 2007, 79:81-85.
17. Giliani S., Bonfim C., de Saint Basile G., et al. Omenn syndrome in an infant with IL7RA gene mutation. J Pediatr 2006, 148:272-274.
18. Roifman C.M., Zhang J., Atkinson A., et al. Adenosine deaminase deficiency can present with features of Omenn syndrome. J Allergy Clin Immunol 2008, 121(4):1056-1058.
19. van der Burg M., van Veelen L.R., Verkaik N.S., et al. A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation. J Clin Invest 2006, 116:137-145.
20. Makitie O., Kaitila I. Cartilage-hair-hypoplasia-clinical manifestations in 108 Finnish patients. Eur J Pediatr 1993, 152:211-217.
21. Santisteban I., Arredondo-Vega F.X., Kelly S., et al. Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA. Hum Mol Genet 1995, 4:2081-2087.
22. Roifman C.M. Studies of patients' thymi aid in the discovery and characterization of immunodeficiency in humans. Immunol Rev 2005, 203:143-155.
23. Antoine C., Muller S., Cant A., et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet 2003, 33:1089-1095.
24. Haddad E., Landais P., Friedrich W., et al. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. Blood 1998, 91:3646-3653.
25. Caillat-Zucman S., Le Deist F., Haddad E., et al. Impact of HLA matching on outcome of hematopoietic stem cell transplantation in children with inherited diseases: a single-centre comparative analysis of genoidentical, haploidentical or unrelated donors. Bone Marrow Transplant 2004, 33:1089-1095.
26. Ball L.M., Lankester A.C., Bredius R.G., et al. Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation. Bone Marrow Transplant 2005, 35(Suppl 1):S35-S38.
27. Dalal I., Reid B., Doyle J., et al. Matched unrelated bone marrow transplantation for combined immunodeficiency. Bone Marrow Transplant 2000, 25:613-621.
28. Guggenheim R., Somech R., Grunebaum E., et al. Bone marrow transplantation for cartilage-hair-hypoplasia. Bone Marrow Transplant 2006, 38:751-756.
29. Nahum A., Reid B., Grunebaum E., et al. Matched unrelated bone marrow transplant for Omenn syndrome. Immunol Res 2009, 44(1-3):25-34.
30. Somech R., Kavadas F.D., Atkinson A., et al. High-dose methylprednisolone is effective in the management of acute graft-versus-host disease in severe combined immune deficiency. J Allergy Clin Immunol 2008, 122(6):1215-1216.
31. Grunebaum E., Mazzolari E., Porta F., et al. Bone marrow transplantation for severe combined immune deficiency. JAMA 2006, 295(5):508-518.